Arcadia Biosciences, Inc. (RKDA)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Net (loss) income attributable to common stockholders | -4,458 | 2,599 | -1,612 | |
| Unrealized gains on available-for-sale securities | - | - | - | |
| Reclassification adjustment for gains on available-for-sale securities included in net (loss) income | - | - | - | |
| Change in unrealized gains on available-for-sale securities | - | - | - | |
| Comprehensive (loss) income | -4,458 | 2,599 | -1,612 | |
| Earnings per share, basic | -3.26 | 1.9 | -1.18 | |
| Earnings per share, diluted | -3.26 | 1.9 | -1.18 | |
| Weighted average shares - basic | 1,367,040 | 1,366,060 | 1,363,753 | |
| Weighted average shares - diluted | 1,367,040 | 1,366,203 | 1,363,753 | |